• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2012 Fiscal Year Final Research Report

Novel biomarkers for childhood idiopathic nephrotic syndrome

Research Project

  • PDF
Project/Area Number 22591196
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionNational Research Institute for Child Health and Development

Principal Investigator

ITO Shuichi  独立行政法人国立成育医療研究センター, 器官病態系内科部, 腎臓・リウマチ・膠原病科医長 (20336572)

Co-Investigator(Kenkyū-buntansha) IMAGOME Kenichi  (独)国立成育医療研究センター, 母児感染研究部感染防御研究室, 室長 (70304780)
ABE Jun  (独)国立成育医療研究センター, 免疫アレルギー研究部免疫療法研究室, 室長 (40281688)
Project Period (FY) 2010 – 2012
Keywordsネフローゼ症候群 / 小児 / リンパ球 / CD40 / CD40 ligand
Research Abstract

Idiopathic nephrotic syndrome is one of the commonest kidney diseases in children. However, its etiology is not elucidated yet. We have evaluated the expression of co-stimulatory molecules on T and B lymphocytes (CD26, CD28、CD80/CD86、CTLA-4、CD69、CD26)by flow cytometry in 11 children with idiopathic nephrotic syndrome. In the result, CD40 ligand expressed on CD4 positive T lymphocyte and CD40 molecule expressed on CD19 positive B lymphocyte are significantly increased at primary onset comparing to at remission and in control children. In addition, western blot analysis revealed that phosphorylated-junk (p-junk), which is in downstream of CD40 signal, is only expressed in patients in active nephorotic phase. These findings suggest that T and B lymphocytes through CD40 and CD40 ligand could play some important role in pathogenesis of nephrotic syndrome. In addition, serum level of soluble CD30 is also significantly increased at primary onset comparing to at remission and in control children. CD30 is also expressed on activated T lymphocyte. Although further investigation is necessary, this finding also suggests mutual activation between T and B lymphocytes. CD40, CD40 ligand and soluble CD30 may be a good candidate of biomarker of nephritic syndrome.

  • Research Products

    (17 results)

All 2013 2012 2011 2010

All Journal Article (10 results) (of which Peer Reviewed: 10 results) Presentation (5 results) Book (2 results)

  • [Journal Article] Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome.2013

    • Author(s)
      Ito S, Kemei K, Ogura M, Udagawa T, Fujinaga S, Saito M, Sako M, Iijima K
    • Journal Title

      Pediatr Nephrol

      Volume: 28 Pages: 257-64

    • DOI

      doi:10.1007/s00467-012-2319-1

    • Peer Reviewed
  • [Journal Article] Atyoical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatr2013

    • Author(s)
      Sato M, Ito S, Ogura M, Kamei K, Miyairi I, Miyata I, Higuchi M, Matsuoka K
    • Journal Title

      Nephrol

      Volume: 28 Pages: 145-1491

    • DOI

      doi:10.1007/s0467-012-2286-6

    • Peer Reviewed
  • [Journal Article] Disease Course in Childhood Steroid Sensitive Nephrotic Syndrome Is it Changeable.2012

    • Author(s)
      Ito S
    • Journal Title

      Ind J pediatr

      Volume: 49 Pages: 868-9

    • Peer Reviewed
  • [Journal Article] Focal segmental glomerulosclerosis in patients with complete deletion of one WT1 allele.2012

    • Author(s)
      Iijima K, Someya T, Ito S, Nozu K, Nakanishi K, Matsuoka K, Ohashi H, Nagata M, Kamei K, Sasaki S
    • Journal Title

      Pediatrics

      Volume: 129 Pages: e1621-5

    • DOI

      doi:10.1542/peds.2011-1323.

    • Peer Reviewed
  • [Journal Article] for the Japanese Study Group of Renal Disease in Children. Two-Year Follow-Up of a Prospective Clinical Trial of Cyclosporine for Frequently Relapsing Nephrotic Syndrome in Children.2012

    • Author(s)
      Ishikura K, Yoshikawa N, Nakazato H, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Ito S, Yata N, Ando T, Honda M
    • Journal Title

      Clin J Am Soc Nephrol

      Volume: 7 Pages: 1576-1583

    • DOI

      doi:10.2215/CJN.00110112

    • Peer Reviewed
  • [Journal Article] Maintenance therapy with MMF after rituximab in pediatric patients with steroid-dependent nephrotic syndrome.2011

    • Author(s)
      Ito S, Kamei K, Ogura M, SatoM, Fujimaru T, Ishikawa T, Udagawa T, Iijima K
    • Journal Title

      Pediatr Nephrol

      Volume: 26 Pages: 1823-1828

    • Peer Reviewed
  • [Journal Article] Cyclophosphamide followed by Mizoribine as maintenance therapy against refractory steroid dependent nephrotic syndrome.2011

    • Author(s)
      Ito S, Ikeda H, harada T, Kamei K, Takahashi E
    • Journal Title

      Pediatr Nephrol

      Volume: 26 Pages: 1921-2

    • Peer Reviewed
  • [Journal Article] Expression of Toll-like receptor 9 in renal podocytes in childhood-onset active and inactive lupus nephritis.2010

    • Author(s)
      Machida H, Ito S, Hirose T, Takeshita F, Oshiro H, Nakamura T, Mori M, Inayama Y, Yan K, Kobayashi N. Yokota S
    • Journal Title

      Nephrol Dial Transplant

      Volume: 25 Pages: 2530-2537

    • Peer Reviewed
  • [Journal Article] Long-term remission of nephritic syndrome with etanercept for concomitant juvenile idiopathic arthritis.2010

    • Author(s)
      Ito S, Tsutsumi A, Harada T, Inaba A, Fujinaga S, Kamei K
    • Journal Title

      Pediatr Nephrol

      Volume: 25 Pages: 2175-2177

    • Peer Reviewed
  • [Journal Article] Single infusion of rituxibmab for persistent steroid-dependent minimal-charge nephritic syndrome after long-term cyclosporine.2010

    • Author(s)
      Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K
    • Journal Title

      Pediatr Nephrol

      Volume: 25 Pages: 539-544

    • Peer Reviewed
  • [Presentation] 分子標的療法がもたらす腎臓疾患治療の未来2012

    • Author(s)
      伊藤秀一
    • Organizer
      第47回日本小児腎臓病学会学術集会
    • Place of Presentation
      東京
    • Year and Date
      2012-06-30
  • [Presentation] Treatment for Refractory Nephrotic Syndrome;Other Immunosuppressive Drugs.2011

    • Author(s)
      Ito S
    • Organizer
      The 11th Asian Congress of Pediatric Nephrology
    • Place of Presentation
      福岡
    • Year and Date
      2011-06-02
  • [Presentation] National survey of rituximab treatment for childhood idiopathic nephritic syndrome.2011

    • Author(s)
      Ito S, Kamei K, Udagawa T, Ogura M, Fujimaru T, Ishikawa T, Sato M, Fujinaga S, Iijima K
    • Organizer
      The 11th Asian Congress of Pediatric Nephrology
    • Place of Presentation
      福岡
    • Year and Date
      2011-06-02
  • [Presentation] Efficacy of Maintenance Therapy with Mycophenolate Mofetil after Rituximab for Steroid-Dependent Nephrotic Syndrome.2011

    • Author(s)
      Ito S, Udagawa T, Ogura M, Mayumi S, Kamei K, Iijima K
    • Organizer
      Pediatric Academic Societies and Asian Sodiety for Pediatric Reserch Joint Meeting,
    • Place of Presentation
      Denver, USA
    • Year and Date
      2011-05-02
  • [Presentation] ネフローゼ症候群におけるT細胞、B細胞間の共刺激分子の発現と病態との関連性について2010

    • Author(s)
      伊藤秀一、堤 晶子、野田俊輔、宇田川智宏 小椋雅夫、亀井宏一
    • Organizer
      第45回小児腎臓病学会学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2010-07-02
  • [Book] こどもの腎炎・ネフローゼ2012

    • Author(s)
      伊藤秀一
    • Total Pages
      202
    • Publisher
      メディカルトリビューン
  • [Book] 小児科臨床ピクシス22 小児のネフローゼと腎炎2010

    • Author(s)
      伊藤秀一
    • Total Pages
      222
    • Publisher
      中山書店

URL: 

Published: 2014-08-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi